The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44.
Halliburton
HAL · a US exchange · USD · Market cap $26.4B · 46,000 employees
Halliburton Company provides products and services to the energy industry worldwide.
PASS · Titan Ethical · score 80.5Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price31.73 USD at the 19 Nov 2026 close
- Our value readFair vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 18 Nov 2026
- Ethical screenPasses, score 80.5 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.25)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $26.10 to $38.99, base estimate $33.91 (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.25, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Halliburton holds its Distribution at $31.73. The statistical read favours the sellers, held for 199 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 199 days |
| Price at the screen | $31.73 |
| Valuation | 13.39 trailing · 10.85 forward price to earnings |
| Values screen | PASS · score 80.5 |
| Beta | 0.75 |
Five Screens: HAL's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 32.52% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 28.58% | Below 49% | Pass |
| Revenue purity | 0.42% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
Halliburton clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 33%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when HAL's ethical verdict changes
Today HAL passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades at roughly a 6% discount to our $33.91 fair value, narrow competitive moat, 1.80% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 6.4% discount to the base estimate.
Third-party analyst targets: 25 covering, consensus Buy. The average target sits +36% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $33.91, with a range of $26.10 to $38.99, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsOil services name flashes cheap but cycles bite
Picture a rig crew working flat out when crude prices spike. Halliburton rides those waves with a narrow moat, 15 percent return on equity and a forward multiple of just 12 times. Revenue sits flat and margins are only 7 percent, yet the shares trade right on our fair value line with an ethical screen cleared.
That low multiple draws attention in a sector where analysts see further upside. Still, a cyclical business showing zero top-line growth rarely offers a true bargain when earnings sit near their peak. The modest discount to our value does not change the pattern that has caught investors before.
Risk sits in the familiar energy trap where a low multiple signals fading demand rather than an overlooked gem. When the cycle turns, the narrow moat offers little protection and multiples can compress further.
Analysis, not advice.
| Forward P/E | 10.8xexpensive even after accounting for its growth |
| Trailing P/E | 13.4xreasonably valued |
| EPS, trailing | 2.38 |
| EPS, forward | 2.94 |
| Revenue growth | +1.8%slow but positive growth |
| Profit margin | 8.9%thin but positive margins |
| Return on equity | 18.8%a solid return on shareholder capital |
| FCF yield | 6.20% |
| Dividend yield | 2.13% |
| Debt to equity | 0.73moderate, manageable leverage |
| Current ratio | 2.02comfortably covers its short-term bills |
| Beta | 0.75steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 24.92 - 43.59 |
| Moat | NARROW |
| Market cap | $26.4B |
| Employees | 46,000 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 88%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (25 analysts) rates it buy, with a mean price target of $44. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Egypt’s EGPC agrees 50-well programme preparations with Halliburton Yahoo Finance · 7d ago
- Halliburton Expands Geothermal Footprint With Sage Geosystems Deal Yahoo Finance · 8d ago
- Sage Geosystems Selects Halliburton to Support Deployment of Proprietary EGS Technology at Project Vector Yahoo Finance · 9d ago
- Halliburton Announces Dividend Yahoo Finance · 9d ago
- Barite - Global Strategic Business Report: Capitalize on the $2 Billion 2032 Shift as Halliburton, SLB, Ashapura, and SCR-Sibelco Reshape Global Supply and Demand Yahoo Finance · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | BECKWITH VAN H. | Officer | 198,349 | $8,189,830 | |
| 2026-05-05 | MAXWELL MICHAEL CASEY | Officer | 20,348 | $852,445 | |
| 2026-04-30 | YOUNG TOBI M. EDWARDS | Director | 6,125 | $255,538 | |
| 2026-04-30 | MCKEON TIMOTHY M. | Officer and Treasurer | 8,655 | $363,510 | |
| 2026-03-27 | MILLER JEFFREY ALLEN | Chief Executive Officer | 158,455 | $6,338,200 | |
| 2026-03-16 | BECKWITH VAN H. | Officer | 19,618 | $663,481 | |
| 2026-03-16 | SLOCUM JEFFREY SHANNON | Chief Operating Officer | 5,441 | $184,015 | |
| 2026-03-06 | MCKEON TIMOTHY M. | Officer and Treasurer | 3,846 | $132,187 | |
| 2026-02-27 | SLOCUM JEFFREY SHANNON | Chief Operating Officer | 8,845 | $318,420 | |
| 2026-02-27 | YASSINE RAMI | Officer | 5,897 | $212,292 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-29 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-09-29 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-09-29 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-09-29 | Gil Cisneros | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $40.09 | -0.3% | $0.17 | $1,001 | +0.1% |
| 2 months | $37.43 | +6.7% | $0.17 | $1,072 | +7.2% |
| 3 months | $34.69 | +15.2% | $0.17 | $1,157 | +15.7% |
| 6 months | $28.86 | +38.5% | $0.34 | $1,396 | +39.6% |
| 1 year | $21.26 | +88.0% | $0.68 | $1,912 | +91.2% |
| 2 years | $32.85 | +21.7% | $1.36 | $1,258 | +25.8% |
| 3 years | $30.22 | +32.2% | $2.02 | $1,389 | +38.9% |
| 5 years | $21.85 | +82.9% | $2.91 | $1,962 | +96.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HAL does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.